Figure 4From: Liver and renal safety of tenofovir disoproxil fumarate in combination with emtricitabine among African women in a pre-exposure prophylaxis trial Cumulative probability of grade 1+ AST toxicity, with number of participants at risk at the start of 4-week intervals (log-rank test, stratified on site, p = 0.025). Back to article page